Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vitti

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
Journal of Endocrinological Investigation|July 29, 2016
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathyE Sabini, E Sisti, B Coco, et al.
Clinical Endocrinology|January 26, 2013
Prevalence of activating thyrotropin receptor and Gsα gene mutations in paediatric thyroid toxic adenomas: a multicentric Italian studyP Agretti, M Segni, G De Marco, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1983
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assayP Vitti, C M Rotella, W A Valente, et al.
Journal of Endocrinological Investigation|September 1, 2017
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patientsM Leo, E Sabini, I Ionni, et al.
Clinical Endocrinology|November 9, 2010
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)C Romei, B Cosci, G Renzini, et al.
Journal of Endocrinological Investigation|July 29, 2016
The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal studyL Bartalena, E Masiello, F Magri, et al.
Journal of Endocrinological Investigation|October 14, 2016
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trialM Leo, L Bartalena, G Rotondo Dottore, et al.
Journal of Endocrinological Investigation|April 5, 2015
Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancyE Gianetti, L Russo, F Orlandi, et al.
Endocrine-Related Cancer|August 4, 2011
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancerB Cosci, A Vivaldi, C Romei, et al.
International Journal of Obesity (2005)|February 1, 2006
Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a Color Doppler Imaging StudyV Di Bello, F Santini, A Di Cori, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Journal of Endocrinological Investigation|July 29, 2016
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathyE Sabini, E Sisti, B Coco, et al.
Clinical Endocrinology|January 26, 2013
Prevalence of activating thyrotropin receptor and Gsα gene mutations in paediatric thyroid toxic adenomas: a multicentric Italian studyP Agretti, M Segni, G De Marco, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1983
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assayP Vitti, C M Rotella, W A Valente, et al.
Journal of Endocrinological Investigation|September 1, 2017
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patientsM Leo, E Sabini, I Ionni, et al.
Clinical Endocrinology|November 9, 2010
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)C Romei, B Cosci, G Renzini, et al.
Journal of Endocrinological Investigation|July 29, 2016
The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal studyL Bartalena, E Masiello, F Magri, et al.
Journal of Endocrinological Investigation|October 14, 2016
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trialM Leo, L Bartalena, G Rotondo Dottore, et al.
Journal of Endocrinological Investigation|April 5, 2015
Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancyE Gianetti, L Russo, F Orlandi, et al.
Endocrine-Related Cancer|August 4, 2011
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancerB Cosci, A Vivaldi, C Romei, et al.
International Journal of Obesity (2005)|February 1, 2006
Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a Color Doppler Imaging StudyV Di Bello, F Santini, A Di Cori, et al.
Pageof 19